The agenda that created pharma’s future

150Research Calls

We guarantee our topics are relevant to you – having spent over 150 hours speaking to pharma executives like you.

100Insightful Sessions

Covering everything from big picture to the devilish details. Use the filters to choose which topics get you going.

1Big Theme

‘Where pharma and patients accelerate the value roadmap’: Let’s find out how pharma can be the total solution and be rewarded for it.

Explore our 2019 Agenda Session Highlights


Fireside chat: Forget Empowerment: Patients as Partners in Innovation, Education and More
  • How the smartest companies are able to go beyond empowerment, beyond advocacy and work with patients for sustained access in a virtuous circle

Percival Barretto-Ko

President, Americas


Marc Boutin

Chief Executive Officer

National Health Council

Fireside chat: Value Rewind: How Pharma can Demonstrate Meaningful and Measurable Impact by Redefining Value from the Patient Perspective
  • Understand the changing landscape of patient-centered drug development, and the move to quantify the qualitative and validate the subjective
  • Find out how pharma can incorporate the patient perspective into R&D in scientifically rigorous and meaningful ways
  • Hear how to scale patient insights into value frameworks that resonate across the health ecosystem – from regulators and payers, to patients and providers

Peter Anastasiou

Executive Vice President, North America


Panel: Unite Patients, Providers and Payers to Bring Preventative Care to Life
  • Preventative care changes lives: how we can transform patient health care experience
  • Go beyond unmet needs to address individual’s pre-disease
  • Align stakeholders to create the market for prevention, interception and cure solutions

Ben Wiegand

Global Head, World Without Disease Accelerator

Janssen R&D

Avi Spira, MD, MsC.

Global Head of Lung Cancer Initiative

Janssen R&D

Anish Suri, Ph.D.

Chief Scientific Officer

Cue Biopharma

Steve Catani

SVP, Innovation

United Healthcare Group, R&D

Partner Your Way to a Real Solution
  • What’s your partnership approach? How to identify the organizations that will take your offerings to a completely different level
  • How to combine digital, digital therapeutic, devices and service into a single unit, designed around the ultimate customer.

Michelle Carnahan

North America Head of Primary Care Business Unit


It’s Riskier Not to Change! Develop a Smarter Business Model for Commercial Pharma
  • How patient activation can better be achieved through intelligent data-linking and targeted outreach
  • How an individualized approach to physicians can enhance patient-physician interaction – and benefit you too

Gillian Cannon



Commercial Excellence

Partner with Providers to Transform Patient Experience
  • Patient Experience requires salesforce to think beyond the product to deliver value
  • Connect and collaborate with your providers to improve patient outcomes
  • Case Study: How AstraZeneca partnered with Geisinger to give Asthma patients mHealth support

Tosh Butt

Senior Vice President, Brazil and Latin America


Building a Culture to Capitalize on Analytical Insights
  • Use a ground-up approach to ensure that your company works effectively with new data
  • Translate insights into solid, actionable steps for success
  • Understand your analytics teams to capitalize on their work and ensure integration between them

Mike Injaychock

Executive Director, Data and Analytics


Lost in Translation: Why Your Teams Don't Execute Your Strategy
  • Pinpoint dysfunction in commercial strategy through internal diagnostics
  • Align leaders to evidence-driven best practice for the era of digital and value-based case
  • Audit your internal process to create a blueprint to empower field force to succeed

James Brewer

Director, Global Commercial Operations

Eli Lilly

Dean McAlister

Senior VP, Client Relationship Development

STEM Healthcare

Mina Makar

SVP US Respiratory and Infectious Disease


Dan Zuniga

Vice President of Marketing

AMAG Pharmaceuticals

Dave Giles

National Sales Director, Neurology – Autoimmune and Rare Diseases

Mallinckrodt Pharmaceuticals

How to create a more engaged and engaging sales force
  • Discover what leading companies are doing to drive winning behaviours, recruit top talent and train for success
  • Gain insights into how the power of purpose can ignite top performers, engage customers and contribute to better outcomes
  • Gain insights into how top sellers use the power of purpose to engage customers and strive for patient outcomes

Jennifer Muszik

US Commercial Learning Lead


David Fortanbary

Head of North America Commercial Training


Bryan Selby

Vice President, Sales & Marketing


Jill Donahue



Train and develop field force capable of successfully engaging IDNs
  • Overcome ingrained habits to restructure teams around KAM principles
  • Throw away sales incentives and train field force to collaboratively engage to discover value
  • Apply customer-centric principles to take insights through a design process that creates customer solutions

Matt Portch

Vice President, Managed Markets


Digital & Customer Experience

Adopt Data-Driven Strategy While Protecting Customer Privacy
  • Translate the promise of omni-channel strategy into a roadmap for operational implementation
  • How to manage a holistic customer approach that sets clear boundaries for customer privacy
  • Create structures that scale to spread the benefits of analytics without compromising compliance

Chapman Richardson

Global Head of Data Consumerization


Panel: The Operational Blueprint to Finally Get to Omni-Channel Market Engagement
  • How Marketing must adapt, and what to expect from sales reps, in an omni-channel age
  • How to leverage incentives to drive change
  • How to stop inertia, and drive execution with strategy in mind instead

Peter Barschdorff

Vice President, Commercial Insights


Matt Smith

Global Lead, Strategy, Digital & Operations


Debra Hussain

Senior Director of Marketing, Connected Care US Brand Leader

Eli Lilly

Tara Stewart

Worldwide Head, Multi-Channel Hub


Alexander Dudinets

Chief Business Development Officer


Digital Engagement: How Physicians Really Behave Online
  • Transform insights into action based on data collected from more than 4600 medical, science, and research sites
  • Learn how to adapt your digital marketing strategies using data-driven tactics to meet HCPs where they are, with the right message, at the right time

Amy Turnquist

Executive Vice President Of Sales

eHealthcare Solutions

Paul Kudlow

CEO, Founder


Patient Value

Focus on Patient Experience to deliver Patient-Centric Support
  • Put yourself in the shoes of the patient in order to understand unmet needs
  • Analyze patient experience to discover why patients slip through the cracks of PSPs
  • How empathy with the patient set UCB strategy to simplify Patient Access

Peter Stueckemann

Head of Patient Experience & Value


A Systematized Approach for Collecting and Incorporating Patient Insights into Medicines Research & Development
  • Opportunities for meaningfully engaging patients in medicines research, development & delivery
  • Best practices for collecting and incorporating patient insights
  • Assessing the value and impact of patient input
  • Increasing the momentum for patient centered medicines development and delivery

Luther Clark

Deputy Chief Patient Officer


Panel: Patient Partnerships are the Only Path to Value-based Care. So How can we Make Them Work? Why Patient Groups Will Become Pharma's Essential Link to Value Beyond the Pill
  • Perfect Match: learn what pharma and patient groups both require for partnerships to succeed
  • How National Kidney Foundation worked with 25+ pharma partners to translate advocacy into FDA change

Anthony Gucciardo

Senior Vice President, Strategic Partnerships

National Kidney Foundation

Scott Williams

VP, Head of Global Patient Advocacy and Strategic Partnerships

EMD Serono

Regulator Panel: Essential Briefing on the FDA's Work to The Advance Patient Voice
  • Update on current FDA efforts related to patient engagement
  • 21st CC and user fee related commitments to advance the science of patient input (CDRH’s patient preference initiative, CDER/CBER’s PFDD methodological guidance development, etc.)
  • How can patient experience data inform key stakeholders (e.g., patient stakeholders, medical product developers, regulators) and what opportunities are there for stakeholders

Pujita Vaidya

Senior Advisor, Patient-Focused Drug Development Program


Samir Shaikh

Deputy Director, Patient Affairs


Michelle Tarvar

Director of Patient Science & Engagement


Patient Centricity 2.0
  • Join this interactive session with real-time feedback
  • Assess where your company stands on 9 domains of patient centricity
  • Ask questions that challenge the status quo, and leave with new ideas on how to deliver Patient Centricity 2.0"

Amy Nicole Nayar

Head of Global Patient Relations


The Importance of Advocacy Groups in Driving Next Generation Patient-Centric Platforms and Engagement
  • Leverage the powerful relationship and credibility that advocacy has with patients
  • Deliver value to the patient by partnering with advocacy groups and navigating the complexity of patient engagement
  • Partner with advocacy to transform the broader health care ecosystem.

Hope Wohl


Kalahn Taylor-Clark

Associate Vice President and Head of Public Affairs, Cardiometabolic Health, US External Affairs


Susan Thornton


Cutaneous Lymphoma Foundation


Jonathan Fox

Specialist Leader

Deloitte Consulting

Medical Affairs

Now or Never: It’s Time for Medical Leadership
  • Seize the initiative and lead the cross-functional effort to present pharma’s authentic face and deliver real value
  • Use this window of opportunity to establish medical’s strategic position in your company
  • How medical can own the response to value-based customer decisions
  • Shape your medical function as a future model for your company, based on scientific authenticity and patient importance

Eliav Barr

Senior Vice President and Head, Global Medical Affairs

Merck Research Laboratories

Panel: Speak the Language of Your Consumer to Increase Engagement
  • Use technology and new information channels to better engage with patients
  • Share information the way consumers want to receive their information in today’s world
  • Use Medical’s role as the scientific face of the company to impart knowledge impartially and become the trusted knowledge source
  • Navigate the Regulatory environment when adapting to new digital platforms

Jimmie Overton

Vice President Global Medical Scientific Information


Michele Sharp

Senior Director, Regulatory Affairs

Eli Lilly

Kelly Wygal

Vice President, Data, Evidence and Insights

Mckesson Life Sciences

Reagan Tully

Vice President, Office of Customer Focus and Delivery

RxCrossroads by Mckesson Life Sciences

Jodie Sherman Gillon

Former Global Medical Lead, Patient Engagement Rare Diseases


Tomorrow’s MSL, today. How Technology and New Attitudes Will Make the MSL the Only F2F Representative
  • See why commercial field roles will be redundant in future payer discussions that require a deeper level of understanding.
  • Develop the skills necessary for Medical to be the only F2F representative and provide more ROI than the current model

Robert Cuddihy

Vice President U.S. Medical Affairs


Cement RWE’s Utility Through Medical Co-leadership
  • Integrate Medical, Commercial & Outcomes Research team to broaden access of Real-World Evidence to external stakeholders
  • Understand data gaps and how Real-World Evidence can provide a sound scientific platform for data generation for physicians

Sonal Bhatia

Vice President, North America Medical Lead, Rare Diseases


Panel: Patient-centric Care: Does the Doctor Know Best?
  • Bridge the communication gap between medical doctors and everyday patients can dramatically improve outcomes
  • How to improve effectiveness for skeptical, time-pressured doctors
  • Real-world, scalable strategies to help doctors connect with their patients’ individual wants and needs

Lynn Nye

Chief Executive Officer

Medical Minds

Mia Nease

Head of Healthcare and Life Science Partnerships

Arivale Patients

Fasiha Haq

Global Medical Education, Rheumatology

Eli Lilly

Sven Gierlinger

Chief Experience Officer

Northwell Health

Stewart Gandolf

Chief Executive Officer

Healthcare Success

Market Access Innovation

Supporting the Commercial Organization to Achieve Value-Based Market Access
  • Learn about critical leadership and collaboration principles to achieve success

Shontelle Dodson

Senior Vice President, Healthcare Systems


Panel: Affordability – The New Buzzword for Market Access
  • Create mindset shifts within your access team to focus on affordability
  • Promote affordability through the integration of evidence that will shape policy

Muna Bhanji

Senior Vice President, Global Market Access


Jeny McNair

Senior Medical Director


Robert Dubois

Executive Vice President and Chief Science Officer

National Pharmaceutical Council

Where Rubber Hits the Road: Value Based Contracts in Practice
  • What lessons can we learn from previous attempts at VBC?
  • Write a roadmap for future VBC agreements that go beyond theory and into practice

Ira Klein

Senior Director, Healthcare Quality Strategy


Michael Kolodziej

Former National Medical Director, Oncology Solutions


Scooter Plowman

Senior Medical Director

Proteus Digital Health


Develop an Integrated Strategy for Evidence Generation
  • Provide decision makers with a more complete value story earlier for faster market access
  • Moving from traditional sequential evidence generation to an integrated strategy, to provide better vale for patients

Mike Spencer

Vice President, Market Access Oncology


Pharma Stays Essential In The Era of Digital Care
  • Digital care can cut costs, improve outcomes and transform the patient experience
  • No one can go it alone: why digital health depends on Pharma & tech symbiosis
  • How Novo Nordisk’s non-exclusive approach to data sharing leads to patient benefit

Christine Farmer

VP Commercial Planning & Operations

Novo Nordisk

Chasing the elusive goal: data and analytics driving policy
  • Reflect on what organizations have already achieved through data and analytics.
  • Learn what more beyond those accomplishments is needed to ensure that Data Scientists and Business Leaders can inform policy decisions

Névine Zariffa

Senior Vice President, Biometrics and Information Sciences


Value-based Contracting Based on Real-world Insights
  • Understanding the complexities and challenges of value based purchasing payments
  • Value-based contracting in the government setting (both federal and state)– Navigating policies and litigation risks

Tamar Thompson

Head, Federal Payment Policy & State Government Affairs/Alliance Development

Bristol-Myers Squibb

How to Establish an Effective RWE Strategy Across your Product Lifecycle
  • Involve R&D colleagues from Phase II onwards to incorporate endpoints that align with RWE goals
  • Choose the appropriate data sources and methodological approaches to structure and analyze data to produce viable action plans
  • Establish a robust partnership ecosystem that enables the effective deployment of the RWE strategy

Christopher Boone

Vice President, Global Real-World Evidence Center of Excellence, Patient & Health Impact